Global Dry Eye Syndrome Competitive Landscape Professional Research Report 2025
Research Summary
Dry eye syndrome, also known as keratoconjunctivitis sicca, is a common eye condition characterized by insufficient moisture and lubrication on the surface of the eyes. This occurs when the eyes either do not produce enough tears or when the tears evaporate too quickly. Dry eye syndrome can lead to discomfort, irritation, a gritty or sandy feeling in the eyes, redness, blurred vision, and sensitivity to light. It can be caused by various factors, including aging, environmental conditions, certain medications, hormonal changes, and underlying health conditions. Management of dry eye syndrome involves using artificial tears, warm compresses, lifestyle adjustments, and sometimes prescription medications, all aimed at relieving symptoms and improving the tear film stability to enhance eye comfort and health.
According to DIResearch's in-depth investigation and research, the global Dry Eye Syndrome market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Dry Eye Syndrome include Allergan, Alcon, Novartis, Santen Pharma, Johnson & Johnson, Bausch & Lomb, Thea pharmaceuticals, SIMILASAN, URSAPHARM, Akorn, United Laboratories, Sun Pharmaceutical, Eusan etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Dry Eye Syndrome. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Dry Eye Syndrome market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Dry Eye Syndrome market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Dry Eye Syndrome industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Dry Eye Syndrome Include:
Allergan
Alcon
Novartis
Santen Pharma
Johnson & Johnson
Bausch & Lomb
Thea pharmaceuticals
SIMILASAN
URSAPHARM
Akorn
United Laboratories
Sun Pharmaceutical
Eusan
Dry Eye Syndrome Product Segment Include:
Artificial Tears
Anti-inflammatory Drugs
Others
Dry Eye Syndrome Product Application Include:
Hospital
Drug Stores
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Dry Eye Syndrome Industry PESTEL Analysis
Chapter 3: Global Dry Eye Syndrome Industry Porter’s Five Forces Analysis
Chapter 4: Global Dry Eye Syndrome Major Regional Market Size and Forecast Analysis
Chapter 5: Global Dry Eye Syndrome Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger Dry Eye Syndrome Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Dry Eye Syndrome Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Dry Eye Syndrome Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Dry Eye Syndrome Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Dry Eye Syndrome Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Dry Eye Syndrome Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Dry Eye Syndrome Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
- 1 Dry Eye Syndrome Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Dry Eye Syndrome Product by Type
- 1.2.1 Artificial Tears
- 1.2.2 Anti-inflammatory Drugs
- 1.2.3 Others
- 1.3 Dry Eye Syndrome Product by Application
- 1.3.1 Hospital
- 1.3.2 Drug Stores
- 1.4 Global Dry Eye Syndrome Market Size Analysis (2020-2032)
- 1.5 Dry Eye Syndrome Market Development Status and Trends
- 1.5.1 Dry Eye Syndrome Industry Development Status Analysis
- 1.5.2 Dry Eye Syndrome Industry Development Trends Analysis
- 2 Dry Eye Syndrome Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Dry Eye Syndrome Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Dry Eye Syndrome Market Analysis by Regions
- 4.1 Dry Eye Syndrome Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Dry Eye Syndrome Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Dry Eye Syndrome Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Dry Eye Syndrome Revenue Forecast by Region (2026-2032)
- 5 Global Dry Eye Syndrome Market Size by Type and Application
- 5.1 Global Dry Eye Syndrome Market Size by Type (2020-2032)
- 5.2 Global Dry Eye Syndrome Market Size by Application (2020-2032)
- 6 North America
- 6.1 North America Dry Eye Syndrome Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Dry Eye Syndrome Market Size by Type
- 6.4 North America Dry Eye Syndrome Market Size by Application
- 6.5 North America Dry Eye Syndrome Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Dry Eye Syndrome Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Dry Eye Syndrome Market Size by Type
- 7.4 Europe Dry Eye Syndrome Market Size by Application
- 7.5 Europe Dry Eye Syndrome Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Dry Eye Syndrome Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Dry Eye Syndrome Market Size by Type
- 8.4 China Dry Eye Syndrome Market Size by Application
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Dry Eye Syndrome Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Dry Eye Syndrome Market Size by Type
- 9.4 APAC (excl. China) Dry Eye Syndrome Market Size by Application
- 9.5 APAC (excl. China) Dry Eye Syndrome Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Dry Eye Syndrome Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Dry Eye Syndrome Market Size by Type
- 10.4 Latin America Dry Eye Syndrome Market Size by Application
- 10.5 Latin America Dry Eye Syndrome Market Size by Country
- 10.5.1 Mexico
- 10.5.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Dry Eye Syndrome Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Dry Eye Syndrome Market Size by Type
- 11.4 Middle East & Africa Dry Eye Syndrome Market Size by Application
- 11.5 Middle East & Africa Dry Eye Syndrome Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Dry Eye Syndrome Market Revenue by Key Manufacturers (2021-2025)
- 12.2 Dry Eye Syndrome Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Dry Eye Syndrome Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Allergan
- 13.1.1 Allergan Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Allergan Dry Eye Syndrome Product Portfolio
- 13.1.3 Allergan Dry Eye Syndrome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.2 Alcon
- 13.2.1 Alcon Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 Alcon Dry Eye Syndrome Product Portfolio
- 13.2.3 Alcon Dry Eye Syndrome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.3 Novartis
- 13.3.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Novartis Dry Eye Syndrome Product Portfolio
- 13.3.3 Novartis Dry Eye Syndrome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.4 Santen Pharma
- 13.4.1 Santen Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 Santen Pharma Dry Eye Syndrome Product Portfolio
- 13.4.3 Santen Pharma Dry Eye Syndrome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.5 Johnson & Johnson
- 13.5.1 Johnson & Johnson Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Johnson & Johnson Dry Eye Syndrome Product Portfolio
- 13.5.3 Johnson & Johnson Dry Eye Syndrome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.6 Bausch & Lomb
- 13.6.1 Bausch & Lomb Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 Bausch & Lomb Dry Eye Syndrome Product Portfolio
- 13.6.3 Bausch & Lomb Dry Eye Syndrome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.7 Thea pharmaceuticals
- 13.7.1 Thea pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 Thea pharmaceuticals Dry Eye Syndrome Product Portfolio
- 13.7.3 Thea pharmaceuticals Dry Eye Syndrome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.8 SIMILASAN
- 13.8.1 SIMILASAN Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 SIMILASAN Dry Eye Syndrome Product Portfolio
- 13.8.3 SIMILASAN Dry Eye Syndrome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.9 URSAPHARM
- 13.9.1 URSAPHARM Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 URSAPHARM Dry Eye Syndrome Product Portfolio
- 13.9.3 URSAPHARM Dry Eye Syndrome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.10 Akorn
- 13.10.1 Akorn Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 Akorn Dry Eye Syndrome Product Portfolio
- 13.10.3 Akorn Dry Eye Syndrome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.11 United Laboratories
- 13.11.1 United Laboratories Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.11.2 United Laboratories Dry Eye Syndrome Product Portfolio
- 13.11.3 United Laboratories Dry Eye Syndrome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.12 Sun Pharmaceutical
- 13.12.1 Sun Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.12.2 Sun Pharmaceutical Dry Eye Syndrome Product Portfolio
- 13.12.3 Sun Pharmaceutical Dry Eye Syndrome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.13 Eusan
- 13.13.1 Eusan Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.13.2 Eusan Dry Eye Syndrome Product Portfolio
- 13.13.3 Eusan Dry Eye Syndrome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Dry Eye Syndrome Industry Chain Analysis
- 14.2 Dry Eye Syndrome Industry Raw Material and Suppliers Analysis
- 14.2.1 Dry Eye Syndrome Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Dry Eye Syndrome Typical Downstream Customers
- 14.4 Dry Eye Syndrome Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook